Bausch Health Co. Inc. (BHC) Tops Q2 EPS by 36c

Bausch Health Co. Inc. (NYSE: BHC) reported Q2 EPS of $0.40, $0.36 better than the analyst estimate of $0.04. Revenue for the quarter came in at $2.53 billion versus the consensus estimate of $2.48 billion.

For earnings history and earnings-related data on Bausch Health Co. Inc. (BHC) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• DOJ Unveils $6.5B Healthcare Fraud Crackdown - WSJ
• Ishares Msci South Korea Capped Etf (EWY) call put ratio 1 call to 1.5 puts as share price down 9.3%